|
US20040082509A1
(en)
|
1999-10-12 |
2004-04-29 |
Christophe Bonny |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
US8183339B1
(en)
|
1999-10-12 |
2012-05-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
AU2001268228A1
(en)
|
2000-06-08 |
2001-12-17 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
|
US20040248158A1
(en)
*
|
2003-01-28 |
2004-12-09 |
Loughran Thomas P |
Differentially expressed genes in large granular lymphocyte leukemia
|
|
US7342095B2
(en)
|
2003-02-20 |
2008-03-11 |
University Of South Florida |
Peptidomimetic inhibitors of STAT activity and uses thereof
|
|
US7189694B2
(en)
*
|
2003-04-18 |
2007-03-13 |
University Of Florida Research Foundation, Inc. |
Inhibitors of autophosphorylation protein kinases
|
|
US7566798B2
(en)
|
2003-08-13 |
2009-07-28 |
University Of South Florida |
Platinum complexes and methods of use
|
|
US8227434B1
(en)
|
2003-11-04 |
2012-07-24 |
H. Lee Moffitt Cancer Center & Research Institute, Inc. |
Materials and methods for treating oncological disorders
|
|
US20050288365A1
(en)
*
|
2004-01-06 |
2005-12-29 |
Heidi Kay |
Platinum complexes and methods for inhibiting tumor cell proliferation
|
|
US8669376B2
(en)
|
2004-02-17 |
2014-03-11 |
University Of South Florida |
Cytotoxin compounds and methods of isolation
|
|
AU2005214979B2
(en)
*
|
2004-02-17 |
2009-09-10 |
The Uab Research Foundation |
Cytotoxin compound and method of isolation
|
|
US8080517B2
(en)
|
2005-09-12 |
2011-12-20 |
Xigen Sa |
Cell-permeable peptide inhibitors of the JNK signal transduction pathway
|
|
WO2007031098A1
(en)
|
2005-09-12 |
2007-03-22 |
Xigen S.A. |
Cell-permeable peptide inhibitors of the jnk signal transduction pathway
|
|
WO2007047623A2
(en)
*
|
2005-10-14 |
2007-04-26 |
University Of South Florida |
Methods of inhibiting cell growth and methods of enhancing radiation responses
|
|
DE102006040647A1
(de)
*
|
2006-08-30 |
2008-03-13 |
Robert Bosch Gmbh |
Handwerkzeugmaschine
|
|
WO2008079945A2
(en)
*
|
2006-12-20 |
2008-07-03 |
University Of South Florida |
Rock inhibitors and uses thereof
|
|
EP3327142A1
(en)
*
|
2007-07-13 |
2018-05-30 |
University of Pittsburgh- Of the Commonwealth System of Higher Education |
Virus derived antimicrobial peptides
|
|
WO2009143864A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of chronic or non-chronic inflammatory digestive diseases
|
|
WO2009143865A1
(en)
|
2008-05-30 |
2009-12-03 |
Xigen S.A. |
Use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
US8673910B2
(en)
*
|
2008-06-30 |
2014-03-18 |
H. Lee Moffitt Cancer Center And Research Institute |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US9174969B2
(en)
*
|
2008-07-21 |
2015-11-03 |
University Of South Florida |
Indoline scaffold SHP-2 inhibitors and cancer treatment method
|
|
US9132168B2
(en)
|
2008-08-05 |
2015-09-15 |
University Of South Florida |
Methods of treating cognitive impairment
|
|
KR20110068993A
(ko)
*
|
2008-08-05 |
2011-06-22 |
유니버시티 오브 사우스 플로리다 |
인지장애의 치료방법
|
|
WO2010072228A1
(en)
*
|
2008-12-22 |
2010-07-01 |
Xigen S.A. |
Novel transporter constructs and transporter cargo conjugate molecules
|
|
US8715685B2
(en)
*
|
2009-07-14 |
2014-05-06 |
Lucia Irene Gonzalez |
Stereoisomer peptides and their polymer conjugates for HIV disease
|
|
US9221808B2
(en)
|
2010-04-16 |
2015-12-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Pyridylthiazole-based ureas as inhibitors of Rho associated protein kinase (ROCK) and methods of use
|
|
WO2011160653A1
(en)
|
2010-06-21 |
2011-12-29 |
Xigen S.A. |
Novel jnk inhibitor molecules
|
|
AU2010362444B2
(en)
|
2010-10-14 |
2015-08-06 |
Xigen Inflammation Ltd. |
Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of chronic or non-chronic inflammatory eye diseases
|
|
US9616064B2
(en)
|
2011-03-30 |
2017-04-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Rho kinase inhibitors and methods of use
|
|
WO2013091670A1
(en)
|
2011-12-21 |
2013-06-27 |
Xigen S.A. |
Novel jnk inhibitor molecules for treatment of various diseases
|
|
US9409868B2
(en)
|
2012-01-24 |
2016-08-09 |
H. Lee Moffin Cancer Center and Research Institute, Inc. |
Inhibitors of rho associated protein kinases (ROCK) and methods of use
|
|
JP6233812B2
(ja)
|
2012-03-07 |
2017-11-22 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
選択的ヒストンデアセチラーゼ６阻害剤
|
|
US10098967B2
(en)
|
2012-12-03 |
2018-10-16 |
Ohio State Innovation Foundation |
Self-assembly of therapeutic agent-peptide nanostructures
|
|
WO2014086835A1
(en)
*
|
2012-12-05 |
2014-06-12 |
Ruprecht-Karls-Universität Heidelberg |
Conjugates of proteins and multivalent cell-penetrating peptides and their uses
|
|
WO2014140113A1
(en)
*
|
2013-03-13 |
2014-09-18 |
Biocrine Ab |
Methods for treating and/or limiting development of diabetes
|
|
WO2015197097A1
(en)
|
2014-06-26 |
2015-12-30 |
Xigen Inflammation Ltd. |
New use for jnk inhibitor molecules for treatment of various diseases
|
|
WO2014206427A1
(en)
|
2013-06-26 |
2014-12-31 |
Xigen Inflammation Ltd. |
New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases
|
|
EA201501080A1
(ru)
|
2013-06-26 |
2016-07-29 |
Ксижен Инфлемейшн Лтд. |
Новое применение обладающих способностью проникать в клетку пептидных ингибиторов пути трансдукции сигнала jnk для лечения различных заболеваний
|
|
CN105592850B
(zh)
|
2013-08-06 |
2019-11-15 |
H·李·莫菲特癌症中心研究所公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
WO2015025323A1
(en)
|
2013-08-21 |
2015-02-26 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Treatment of mood and stress related disorders
|
|
US10626178B2
(en)
|
2013-08-21 |
2020-04-21 |
Raz Yirmiya |
Treatment of mood and stress related disorders
|
|
AU2015209143A1
(en)
|
2014-01-23 |
2016-08-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Icariin derivatives
|
|
WO2015112904A1
(en)
|
2014-01-24 |
2015-07-30 |
University Of Florida Research Foundation, Inc. |
Socs mimetics for the treatment of diseases
|
|
US10463684B2
(en)
|
2014-01-29 |
2019-11-05 |
Board Of Regents, The Uneversety Of Texas System |
Nucleobase analogue derivatives and their applications
|
|
WO2015153560A1
(en)
|
2014-03-31 |
2015-10-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Stabilized peptoid-peptide hybrids and uses thereof
|
|
US9987258B2
(en)
|
2014-04-06 |
2018-06-05 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Histone deacetylase as a modulator of PDL1 expression and activity
|
|
ES2980788T3
(es)
|
2014-04-10 |
2024-10-03 |
H Lee Moffitt Cancer Ct & Res |
Expansión mejorada de linfocitos infiltrantes de tumores para terapia celular adoptiva
|
|
HRP20191254T1
(hr)
|
2014-05-21 |
2019-10-18 |
Entrada Therapeutics, Inc. |
Peptidi koji prodiru u stanice i postupci za njihovu proizvodnju i uporabu
|
|
US10815276B2
(en)
|
2014-05-21 |
2020-10-27 |
Entrada Therapeutics, Inc. |
Cell penetrating peptides and methods of making and using thereof
|
|
EP3185880B1
(en)
|
2014-08-27 |
2020-02-12 |
Ohio State Innovation Foundation |
Improved peptidyl calcineurin inhibitors
|
|
WO2016154586A1
(en)
|
2015-03-26 |
2016-09-29 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Toll-like receptor 2 ligands and methods of making and using thereof
|
|
JP6959142B2
(ja)
|
2015-05-06 |
2021-11-02 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
Ｍｃ１ｒを標的とする放射線療法用作用物質およびコンパニオンイメージング作用物質
|
|
WO2016197067A1
(en)
|
2015-06-05 |
2016-12-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Gm-csf/cd40l vaccine and checkpoint inhibitor combination therapy
|
|
CN108348779A
(zh)
|
2015-08-02 |
2018-07-31 |
H·李·莫菲特癌症中心研究有限公司 |
Ack1/tnk2酪氨酸激酶的抑制剂
|
|
ES2989922T3
(es)
|
2015-09-17 |
2024-11-28 |
Ohio State Innovation Foundation |
Compuestos de carborano y métodos de uso de los mismos
|
|
US10738016B2
(en)
|
2015-10-13 |
2020-08-11 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
BRD4-kinase inhibitors as cancer therapeutics
|
|
WO2017100650A1
(en)
|
2015-12-09 |
2017-06-15 |
Vanderbilt University |
Biosynthesis of everninomicin analogs in micromonospora carbonacea var aurantiaca
|
|
WO2017156527A1
(en)
|
2016-03-11 |
2017-09-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Aurora kinase and janus kinase inhibitors for prevention of graft versus host disease
|
|
US11395820B2
(en)
|
2016-03-16 |
2022-07-26 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecules against cereblon to enhance effector t cell function
|
|
RU2018142711A
(ru)
|
2016-05-04 |
2020-06-04 |
Х. Ли Моффитт Кэнсер Сентер Энд Рисёч Инститьют, Инк. |
Средство для целенаправленного воздействия на дельта-опиоидный рецептор для молекулярной визуализации и иммунотерапии рака
|
|
CN110114075B
(zh)
|
2016-11-09 |
2024-01-12 |
俄亥俄州国家创新基金会 |
含有二硫化物的细胞穿透肽及其制备和使用方法
|
|
WO2018098282A2
(en)
|
2016-11-22 |
2018-05-31 |
Ohio State Innovation Foundation |
Cyclic cell penetrating peptides comprising beta-hairpin motifs and methods of making and using thereof
|
|
TW202500573A
(zh)
|
2016-11-22 |
2025-01-01 |
俄亥俄州立創新基金會 |
細胞穿透肽序列
|
|
WO2018098226A1
(en)
|
2016-11-22 |
2018-05-31 |
Ohio State Innovation Foundation |
Bicyclic peptidyl inhibitor of tumor necrosis factor-alpha
|
|
US11583525B2
(en)
|
2017-06-06 |
2023-02-21 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Geranylgeranyltransferase I inhibitor for treatment of a PTEN defective cancer
|
|
WO2019070962A1
(en)
|
2017-10-04 |
2019-04-11 |
Ohio State Innovation Foundation |
BICYCLIC PEPTIDE INHIBITORS
|
|
CN117567639A
(zh)
|
2017-10-27 |
2024-02-20 |
俄亥俄州国家创新基金会 |
用于细胞内递送装订肽的多肽缀合物
|
|
US11793884B2
(en)
|
2018-01-29 |
2023-10-24 |
Ohio State Innovation Foundation |
Cyclic peptidyl inhibitors of CAL-PDZ binding domain
|
|
WO2019148194A2
(en)
|
2018-01-29 |
2019-08-01 |
Ohio State Innovation Foundation |
Peptidyl inhibitors of calcineurin-nfat interaction
|
|
WO2019165183A1
(en)
|
2018-02-22 |
2019-08-29 |
Entrada Therapeutics, Inc. |
Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
|
|
WO2019213662A1
(en)
|
2018-05-04 |
2019-11-07 |
Ohio State Innovation Foundation |
Non-peptidic cell-penetrating motifs
|
|
EP3790890A4
(en)
|
2018-05-09 |
2022-03-02 |
Ohio State Innovation Foundation |
CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
|
|
US11730726B2
(en)
|
2018-07-11 |
2023-08-22 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Dimeric immuno-modulatory compounds against cereblon-based mechanisms
|
|
US10898460B1
(en)
|
2018-07-20 |
2021-01-26 |
University Of South Florida |
Leishmania inhibitors
|
|
WO2020028814A1
(en)
|
2018-08-03 |
2020-02-06 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Allosteric inhibitor of wee1 kinase
|
|
WO2020037116A1
(en)
|
2018-08-17 |
2020-02-20 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Small molecule pyrin-domain targeted nlrp3 inflammasome inhibitors
|
|
US12162856B2
(en)
|
2018-10-18 |
2024-12-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
β-catenin and B-cell lymphoma 9 (BCL9) inhibitors
|
|
US12269899B2
(en)
|
2018-12-07 |
2025-04-08 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Peptidomimetic inhibitors of β-catenin/Tcf protein-protein interaction
|
|
CN114616240A
(zh)
|
2019-11-08 |
2022-06-10 |
高等教育联邦系统-匹兹堡大学 |
包含抗微生物肽的组合物
|
|
KR102811112B1
(ko)
|
2020-01-20 |
2025-05-21 |
삼성전자주식회사 |
매립형 공기청정장치
|
|
WO2021150954A1
(en)
|
2020-01-24 |
2021-07-29 |
Ohio State Innovation Foundation |
Bacterial topoisomerase inhibitors derived from isomannide
|
|
WO2021236852A1
(en)
|
2020-05-20 |
2021-11-25 |
Sana Biotechnology, Inc. |
Methods and compositions for treatment of viral infections
|
|
MX2023011612A
(es)
|
2021-03-31 |
2023-12-15 |
Entrada Therapeutics Inc |
Peptidos de penetracion celular ciclicos.
|
|
US12371463B2
(en)
|
2021-04-20 |
2025-07-29 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Methods and compositions for treatment of antibiotic-resistant bacterial infections
|
|
EP4337263A1
(en)
|
2021-05-10 |
2024-03-20 |
Entrada Therapeutics, Inc. |
Compositions and methods for modulating interferon regulatory factor-5 (irf-5) activity
|
|
CA3217463A1
(en)
|
2021-05-10 |
2022-11-17 |
Ziqing QIAN |
Compositions and methods for modulating mrna splicing
|
|
CA3218805A1
(en)
|
2021-05-10 |
2022-11-17 |
Ziqing QIAN |
Compositions and methods for intracellular therapeutics
|
|
EP4359006A1
(en)
|
2021-06-23 |
2024-05-01 |
Entrada Therapeutics, Inc. |
Antisense compounds and methods for targeting cug repeats
|
|
AU2022339769A1
(en)
|
2021-09-01 |
2024-03-28 |
Entrada Therapeutics, Inc. |
Compounds and methods for skipping exon 44 in duchenne muscular dystrophy
|
|
WO2023219933A1
(en)
|
2022-05-09 |
2023-11-16 |
Entrada Therapeutics, Inc. |
Compositions and methods for delivery of nucleic acid therapeutics
|
|
IL318248A
(en)
|
2022-07-15 |
2025-03-01 |
Entrada Therapeutics Inc |
Hybrid oligonucleotides
|
|
WO2024073042A1
(en)
|
2022-09-30 |
2024-04-04 |
Entrada Therapeutics, Inc. |
Ocular delivery of therapeutic agents
|
|
WO2024115720A1
(en)
*
|
2022-12-01 |
2024-06-06 |
Hairvel Oü |
Novel peptide conjugates
|
|
WO2025038901A1
(en)
|
2023-08-17 |
2025-02-20 |
Entrada Therapeutics, Inc. |
Cyclic peptides for delivering therapeutics
|
|
WO2025038902A2
(en)
|
2023-08-17 |
2025-02-20 |
Entrada Therapeutics, Inc. |
Intracellular targeting of oligonucleotides
|
|
WO2025072246A1
(en)
|
2023-09-26 |
2025-04-03 |
Entrada Therapeutics, Inc. |
Compounds and methods for skipping exon 50 in duchenne muscular dystrophy
|